Bora Pharmaceuticals USA Inc. announced that it will receive $57,000,000 in an equity round of funding on May 14, 2024. The transaction include the participation from returning investor, Bora Pharmaceuticals Co., LTD., hold 100% stake in the company. The transaction has been approved by the board of directors of the company.